Gene · 5144
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring Synergistic Anti-Psoriatic Potential of Bioactive Compounds Tyrosol and Farnesol through In-Silico and In Vitro Approaches. | Curr Protein Pept Sci | 2026 | 41863454 | PubTator, text mining | PubMed |
| Dose-Dependent Inhibition of Protein Glycosylation Reveals Crosstalk between Glycosylation and Phosphorylation in EGF Signaling Pathways. | Anal Chem | 2026 | 41843583 | PubTator, text mining | PubMed |
| BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations. | Mol Biomed | 2026 | 41807883 | PubTator, text mining | PubMed |
| RBM15B promotes hepatocellular carcinoma progression via IGF2BP1-mediated ITSN2 mRNA stabilization. | J Cancer Res Clin Oncol | 2026 | 41795047 | PubTator, text mining | PubMed |
| Tudor domain-containing protein 9-targeting siRNA nanoparticles alleviate Pseudomonas aeruginosa lung injury in preclinical models by promoting neutrophil cuproptosis. | Nat Commun | 2026 | 41792170 | PubTator, text mining | PubMed |
| Biological implications and therapeutic potential of phosphodiesterase inhibitors: A review. | Medicine (Baltimore) | 2026 | 41790675 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis reveals cellular and molecular insights into gestational diabetes mellitus. | Front Mol Biosci | 2026 | 41788625 | PubTator, text mining | PubMed |
| Design, synthesis and exploration of cyclic imides as PDE4 inhibitors in psoriasis. | RSC Med Chem | 2026 | 41777557 | PubTator, text mining | PubMed |
| Inflammatory mechanisms underlying early Alzheimer's disease pathology: evidence from the aging rhesus macaque brain. | Front Cell Neurosci | 2026 | 41767744 | PubTator, text mining | PubMed |
| Molecular Design with Artificial Intelligence: Progress and Perspectives for Small Molecules. | Chem Rev | 2026 | 41764645 | PubTator, text mining | PubMed |
| Biological Treatment of Psoriasis-Data So Far. | Pharmaceuticals (Basel) | 2026 | 41754879 | PubTator, text mining | PubMed |
| MicroRNA Signatures of Prostate Cancer Spheroids in Microfluidic Culture Under Hormone-Deprivation Conditions. | Bioengineering (Basel) | 2026 | 41749743 | PubTator, text mining | PubMed |
| Phosphodiesterase inhibitors as emerging therapeutics for skeletal disorders: A comprehensive review of mechanisms and repurposing potential. | Bone Rep | 2026 | 41732176 | PubTator, text mining | PubMed |
| Catechins in insomnia-Alzheimer's disease comorbidity: A network pharmacology and molecular docking study. | Medicine (Baltimore) | 2026 | 41731757 | PubTator, text mining | PubMed |
| KLINSE: a comprehensive service model for rare disease information and care management support. | Orphanet J Rare Dis | 2026 | 41620789 | PubTator, text mining | PubMed |
| TRPS1 confers paclitaxel resistance in TNBC through dual activation of the PDE4D-cAMP-AKT pathway and microtubule destabilization. | Breast Cancer Res | 2026 | 41559814 | PubTator, text mining | PubMed |
| TSniffer: unbiased de novo identification of RNA editing sites and quantification of editing activity in RNA-seq data. | Genome Biol | 2026 | 41549280 | PubTator, text mining | PubMed |
| Aspirin Downregulates PDE4D to Inhibit Malignant Progression of Osteosarcoma through the NF-κB/p65 Pathway. | Curr Med Chem | 2026 | 41540519 | PubTator, text mining | PubMed |
| Targeting Circadian Rhythm for the Regulation of Skin Collagen Metabolism. | J Cosmet Dermatol | 2026 | 41527525 | PubTator, text mining | PubMed |
| BTSCs exosomes derived NamiRNA-enhancer network of miR-151a-3p mediates a positive feedback loop and promotes the progression of glioma via FAK phosphorylation. | Cancer Lett | 2026 | 41380901 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5144/papers?page=2